Education
About Us
Working with TipRanks
Follow Us
BIO-key International Inc (BKYI)
NASDAQ:BKYI
BKYI Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.52 - $3.68
Previous CloseN/A
Volume225.68K
Average Volume (3M)342.48K
Market Cap
$2.54M
Enterprise Value$6.52M
Total Cash (Recent Filing)$487.97K
Total Debt (Recent Filing)$381.65K
Price to Earnings (P/E)―
Beta1.13
Next Earnings
May 14, 2025EPS Estimate
-0.35Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.23
Shares Outstanding3,127,049
10 Day Avg. Volume320,796
30 Day Avg. Volume342,478
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.52
Price to Cash Flow (P/CF)-0.70
P/FCF Ratio0.00
Enterprise Value/Market Cap2.56
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit4.56
Enterprise Value/Ebitda-0.75
Forecast
1Y Price Target
$3.00Price Target Upside279.75% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
---
BIO-key International News
PremiumCompany Announcements
BIO-key International Delays Annual Report Filing
PremiumCompany Announcements
BIO-key International Reports Reduced Losses Amid Strategic Shift
PremiumCompany Announcements
Bio-Key’s Strategic Shift Boosts Margins Amid Revenue Challenges
PremiumPre-Earnings
Is BKYI a Buy, Before Earnings?---
Bulls Say, Bears Say
Bulls Say
EarningsBKYI reported better-than-expected 3Q24 results with revenue of $2.1M, above the estimate.
Growth PotentialManagement expects 2024 revenue to meet or exceed the $7.75M revenue achieved in 2023, indicating growth potential.
Product InnovationBKYI recently entered the passkey authentication market with the launch of a unique password-less authentication solution.
Bears Say
Delayed OrdersThe primary reason for the revenue miss was due to a delayed $450K order that slipped into 3Q24.
Revenue EstimatesLower 2024 and 2025 revenue and EBIT estimates based on management commentary and continued macro challenges.
---
Ownership Overview
4.88% Insiders
0.57% Mutual Funds
0.50% Other Institutional Investors
93.84% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
BKYI FAQ
What was BIO-key International Inc’s price range in the past 12 months?
BIO-key International Inc lowest stock price was $0.52 and its highest was $3.68 in the past 12 months.
What is BIO-key International Inc’s market cap?
BIO-key International Inc’s market cap is $2.54M.
When is BIO-key International Inc’s upcoming earnings report date?
BIO-key International Inc’s upcoming earnings report date is May 14, 2025 which is in 43 days.
How were BIO-key International Inc’s earnings last quarter?
BIO-key International Inc released its earnings results on Mar 27, 2025. The company reported -$0.53 earnings per share for the quarter, missing the consensus estimate of -$0.35 by -$0.18.
Is BIO-key International Inc overvalued?
According to Wall Street analysts BIO-key International Inc’s price is currently Undervalued.
Does BIO-key International Inc pay dividends?
BIO-key International Inc does not currently pay dividends.
What is BIO-key International Inc’s EPS estimate?
BIO-key International Inc’s EPS estimate is -0.35.
How many shares outstanding does BIO-key International Inc have?
BIO-key International Inc has 3,127,049 shares outstanding.
What happened to BIO-key International Inc’s price movement after its last earnings report?
BIO-key International Inc reported an EPS of -$0.53 in its last earnings report, missing expectations of -$0.35. Following the earnings report the stock price went down -23.214%.
Which hedge fund is a major shareholder of BIO-key International Inc?
Currently, no hedge funds are holding shares in BKYI
---
Company Description
BIO-key International Inc
BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform. Its solutions enable its customers to secure their workforces and student populations; and make their partner networks more collaborative. In addition, it provides BIO-key VST and WEB-key products; and Civil and Large-Scale ID Infrastructure solutions that develops finger-based biometric technology. Further, it offers finger scanners for enterprise and consumer markets under SideSwipe, EcoID, and SidePass brand names. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey.
---
BKYI Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call revealed a strategic shift towards higher-margin products, resulting in improved gross profit and margin. Despite a decline in total revenue due to exiting low-margin services, the company is showing promising growth prospects for 2025 with increased demand for its IAM solutions and several strategic partnerships. However, the decline in hardware and service revenue presents challenges that need addressing.Read More>---
BKYI Stock 12 Month Forecast
Average Price Target
$3.00
▲(279.75% Upside)
Technical Analysis
Nuburu
―
AgriFORCE Growing Systems
―
Dragonfly Energy Holdings Corp
―
SMX Public Limited Company
―
Expion360, Inc.
―
Best Analysts Covering BKYI
1 Year
1 Year Success Rate
0/15 ratings generated profit
1 Year Average Return
-59.24%
reiterated a buy rating 4 months ago
Copying Jack Vander Aarde's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -59.24% per trade.
---